Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance.
- NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_assertion description "[These observations indicate a promising role for IL-13R?2 as a target for antibody treatment in malignant mesothelioma, and, in combination with epigenetic regulation by a DNA methylation inhibitor, suggest the potential for a novel strategy to enhance therapeutic potency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance.
- NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_assertion evidence source_evidence_literature NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance.
- NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_assertion SIO_000772 21357681 NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance.
- NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_assertion wasDerivedFrom befree-20140225 NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance.
- NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_assertion wasGeneratedBy ECO_0000203 NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP643081.RABv5u3m3Hn73d3ZNxHTn-q6oxUZujzs0InNLVTFXGFnI130_provenance.